253 related articles for article (PubMed ID: 22689137)
1. Eyelid procedures in patients who have undergone Boston keratoprosthesis surgery.
Baker MS; Krakauer M; Gupta S; de la Cruz J; Cortina MS; Kitzmann AS; Goins KM; Allen RC; Setabutr P
Ophthalmic Plast Reconstr Surg; 2012; 28(4):286-8. PubMed ID: 22689137
[TBL] [Abstract][Full Text] [Related]
2. Gamma-irradiated corneas as carriers for the Boston type 1 keratoprosthesis: advantages and outcomes in a surgical mission setting.
Fadlallah A; Atallah M; Cherfan G; Awwad ST; Syed ZA; Melki SA
Cornea; 2014 Mar; 33(3):235-9. PubMed ID: 24457451
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Visual Outcomes, Complications, and Retention of the Boston Type I Keratoprosthesis.
Aravena C; Yu F; Aldave AJ
Cornea; 2018 Jan; 37(1):3-10. PubMed ID: 28990994
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Oculoplastic and Ocular Surface Disease in Eyes Implanted with a Type I Boston Keratoprosthesis in Southern China: A Retrospective Study.
Zhang Y; Ou Z; Zhou J; Zhai J; Gu J; Chen J
Adv Ther; 2020 Jul; 37(7):3206-3222. PubMed ID: 32436025
[TBL] [Abstract][Full Text] [Related]
5. Glaucoma associated with Boston type I keratoprosthesis.
Kamyar R; Weizer JS; de Paula FH; Stein JD; Moroi SE; John D; Musch DC; Mian SI
Cornea; 2012 Feb; 31(2):134-9. PubMed ID: 22134402
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of the Boston Type I Keratoprosthesis as the Primary Penetrating Corneal Procedure.
Driver TH; Aravena C; Duong HNV; Christenbury JG; Yu F; Basak SK; Aldave AJ
Cornea; 2018 Nov; 37(11):1400-1407. PubMed ID: 30157053
[TBL] [Abstract][Full Text] [Related]
7. Visual Outcomes and Complications of Type I Boston Keratoprosthesis in Children: A Retrospective Multicenter Study and Literature Review.
Fung SSM; Jabbour S; Harissi-Dagher M; Tan RRG; Hamel P; Baig K; Ali A
Ophthalmology; 2018 Feb; 125(2):153-160. PubMed ID: 28807636
[TBL] [Abstract][Full Text] [Related]
8. Boston keratoprosthesis type 1 surgery: use of frozen versus fresh corneal donor carriers.
Robert MC; Biernacki K; Harissi-Dagher M
Cornea; 2012 Apr; 31(4):339-45. PubMed ID: 22269678
[TBL] [Abstract][Full Text] [Related]
9. Type 1 Boston keratoprosthesis: outcomes at two Canadian centres.
Noel CW; Isenberg J; Goldich Y; Conlon R; Teichman J; Rubinger DA; Weinberg TA; Slomovic J; Chan CC; Rootman DS; Baig KM; Slomovic AR
Can J Ophthalmol; 2016 Apr; 51(2):76-82. PubMed ID: 27085262
[TBL] [Abstract][Full Text] [Related]
10. The Boston Keratoprosthesis type 1 as primary penetrating corneal procedure.
Fadous R; Levallois-Gignac S; Vaillancourt L; Robert MC; Harissi-Dagher M
Br J Ophthalmol; 2015 Dec; 99(12):1664-8. PubMed ID: 26034079
[TBL] [Abstract][Full Text] [Related]
11. The Boston Keratoprosthesis in severe ocular trauma.
Harissi-Dagher M; Dohlman CH
Can J Ophthalmol; 2008 Apr; 43(2):165-9. PubMed ID: 18347618
[TBL] [Abstract][Full Text] [Related]
12. Keratoprostheses in silicone oil-filled eyes: long-term outcomes.
Iyer G; Srinivasan B; Agarwal S; Pattanaik R; Rishi E; Rishi P; Shanmugasundaram S; Natarajan V
Br J Ophthalmol; 2019 Jun; 103(6):781-788. PubMed ID: 30021817
[TBL] [Abstract][Full Text] [Related]
13. Boston type 1 keratoprosthesis: the CHUM experience.
Robert MC; Harissi-Dagher M
Can J Ophthalmol; 2011 Apr; 46(2):164-8. PubMed ID: 21708085
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Outcomes of the Boston Type I Keratoprosthesis in the Management of Corneal Limbal Stem Cell Deficiency.
Aravena C; Bozkurt TK; Yu F; Aldave AJ
Cornea; 2016 Sep; 35(9):1156-64. PubMed ID: 27387566
[TBL] [Abstract][Full Text] [Related]
15. Glaucoma Risk Factors and Outcomes Following Boston Keratoprosthesis Type 1 Surgery.
Geoffrion D; Harissi-Dagher M
Am J Ophthalmol; 2021 Jun; 226():56-67. PubMed ID: 33493469
[TBL] [Abstract][Full Text] [Related]
16. The Boston keratoprosthesis in the management of corneal limbal stem cell deficiency.
Sejpal K; Yu F; Aldave AJ
Cornea; 2011 Nov; 30(11):1187-94. PubMed ID: 21885964
[TBL] [Abstract][Full Text] [Related]
17. The Aurolab Keratoprosthesis (KPro) versus the Boston Type I Kpro: 5-year Clinical Outcomes in 134 Cases of Bilateral Corneal Blindness.
Basu S; Serna-Ojeda JC; Senthil S; Pappuru RR; Bagga B; Sangwan V
Am J Ophthalmol; 2019 Sep; 205():175-183. PubMed ID: 30905723
[TBL] [Abstract][Full Text] [Related]
18. Predictors of visual outcomes following Boston type 1 keratoprosthesis implantation.
Ahmad S; Akpek EK; Gehlbach PL; Dunlap K; Ramulu PY
Am J Ophthalmol; 2015 Apr; 159(4):739-47. PubMed ID: 25555801
[TBL] [Abstract][Full Text] [Related]
19. Incidence, Risk Factors, and Surgical Management of Boston Type 1 Keratoprothesis Corneal Melts, Leaks, and Extrusions.
Chan CC; LoVerde L; Qiang J; Nordlund ML; Holland EJ
Cornea; 2016 Aug; 35(8):1049-56. PubMed ID: 27391092
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
